Nuveen International Equity Index Fund R6 Class (TCIEX)
| Fund Assets | 30.54B |
| Expense Ratio | 0.05% |
| Min. Investment | $10,000,000 |
| Turnover | 4.00% |
| Dividend (ttm) | 0.70 |
| Dividend Yield | 2.63% |
| Dividend Growth | 1.60% |
| Payout Frequency | Annual |
| Ex-Dividend Date | Dec 6, 2024 |
| Previous Close | 20.05 |
| YTD Return | -8.86% |
| 1-Year Return | -10.45% |
| 5-Year Return | 29.19% |
| 52-Week Low | 20.05 |
| 52-Week High | 26.52 |
| Beta (5Y) | 0.84 |
| Holdings | 711 |
| Inception Date | Oct 1, 2002 |
About TCIEX
Nuveen International Equity Index Fund R6 is a mutual fund designed to provide investors with long-term total return, primarily through capital appreciation. The fund achieves this by investing predominantly in a diversified portfolio of foreign equity securities, closely tracking the MSCI EAFE Index, which represents large- and mid-cap companies across developed markets outside the United States and Canada. By allocating at least 80% of its assets to securities within this benchmark, the fund seeks to mirror the overall investment characteristics and performance of international developed market equities. Key holdings typically span sectors such as healthcare, technology, consumer defensive, energy, and industrials, including companies like Novo Nordisk, ASML Holding, and Nestle. Known for its low expense ratio and broad geographic and sector exposure, the fund plays a significant role for institutional and retirement investors seeking efficient, cost-effective access to international equity diversification within a single investment vehicle.
Performance
TCIEX had a total return of -10.45% in the past year, including dividends. Since the fund's inception, the average annual return has been 5.86%.
Top 10 Holdings
13.37% of assets| Name | Symbol | Weight |
|---|---|---|
| SAP SE | SAP | 1.69% |
| ICE US mini MSCI EAFE Index Futures | MFSM5 | 1.57% |
| Nestlé S.A. | NESN | 1.54% |
| ASML Holding N.V. | ASML | 1.46% |
| Roche Holding AG | ROG | 1.27% |
| Novartis AG | NOVN | 1.24% |
| AstraZeneca PLC | AZN | 1.23% |
| Novo Nordisk A/S - Novo Nordisk A.S. | n/a | 1.19% |
| HSBC Holdings plc | HSBA | 1.10% |
| Shell plc | SHEL | 1.09% |
Dividend History
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Dec 6, 2024 | $0.69749 | Dec 9, 2024 |
| Dec 8, 2023 | $0.68651 | Dec 8, 2023 |
| Dec 9, 2022 | $0.53784 | Dec 9, 2022 |
| Dec 10, 2021 | $0.69212 | Dec 10, 2021 |
| Dec 11, 2020 | $0.41626 | Dec 11, 2020 |
| Dec 6, 2019 | $0.61507 | Dec 6, 2019 |